Mercury Laboratories Ltd

Mercury Laboratories: PAT jumps 53.71%, margins expand, ₹30 Crore injectable plant on the way 🏭

- PAT up 53.71% to ₹483.39 Lakhs (prev yr ₹314.49 Lakhs)

- Operating profit margin: 14.12% (prev yr 10.61%)

- ROE increased to 8.32% from 5.87%

- Revenue from operations: ₹7,593.67 Lakhs (growth 1.10%)

- Direct exports up 18.62% to ₹2,472.32 Lakhs

- Domestic sales down 5.61% to ₹5,121.35 Lakhs

- New injectable facility: ₹30 Crores, 75 million units capacity

- EPS: ₹40.28 (prev yr ₹26.21)

- Dividend recommended: ₹3.50 per share (35%)

- Other income: ₹195.51 Lakhs (prev yr ₹106.87 Lakhs)